SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Accounting Policies [Abstract]

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share for the three and nine months ended September 30, 2024 and 2023 because the effect of their inclusion would have been anti-dilutive.

	For the three and nine months ended September 30, 2024		For the three and nine months ended September 30, 2023
Warrants to purchase shares of common stock		844,628		609,893
Restricted stock units - vested and unissued		20,526		20,847
Restricted stock units - unvested		351,616		148,251
Investment options to purchase shares of common stock		70,000		1,070,000
Options to purchase shares of common stock		23,082		31,852
Total potentially dilutive securities		1,309,852		1,880,843

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share the years ended December 31, 2023 and 2022 because the effect of their inclusion would have been anti-dilutive.

	For the years ended December 31,
	2023		2022
Warrants to purchase shares of common stock		2,799,213		655,463
Restricted stock units - vested and unissued		20,848		62,492
Restricted stock units - unvested		140,491		64,053
Restricted stock awards - vested and unissued		—		708
Common stock in abeyance		704,000		—
Investment options to purchase shares of common stock		70,000		1,070,000
Options to purchase shares of common stock		30,329		48,329
Total potentially dilutive securities		3,764,881		1,901,045